Cannabis sativa L. is an ancient plant, with a plethora of possible uses in modern healthcare. Globally, research is slowly but surely starting to explore how its active components can be exploited to combat neurological diseases, chronic pain, cancer and even severe epilepsy in children. Already, many European countries (including Germany, Switzerland and the UK) and Canada have a regulated system in place to allow for the delivery of cannabis-based medicine in pharmacy and on prescription. However, there is a chronic lack of high quality clinical research with standardized material. Aside from the science, the production of standardized cannabis provides an enormous economic growth, creating employment and revenue for both companies and governments.
Our mission is not only to advance the science of cannabis, but also to help patients by providing standardized cannabis products...
Slowly but surely, the European market for pharmaceutical (derived) cannabis products is developing, creating lots of interesting opportunities.
Subscribe to our newsletter